Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252174 · ClinicalTrials.gov registry record · Phase 2
MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer
A Phase 2 study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT00252174: Clinical Trial Phase 2 study, sponsored by Brigham and Women's Hospital.
NCT00252174 is a Phase 2 study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00252174, a Phase 2 study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a pilot study intended to find out if 3,4-methylenedioxymethamphetamine (MDMA) is safe and can help people with advanced stage cancer and anxiety arising from the cancer diagnosis.
Primary Outcome
Established self-report measure of anxiety containing a State and Trait subscale and scored on a four-point Likert scale. Scores for each subscale range from 10 to 40 and combined from 20 to 80 with higher scores indicative of greater anxiety.
Interventions
- BEHAVIORAL Psychotherapy
- DRUG Stage 1 Active Methylenedioxymethamphetamine
- DRUG Stage 1 Low dose Methylenedioxymethamphetamine
- DRUG Stage 2 Active Methylenedioxymethamphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-02 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
Why NCT00252174 stopped before completion
NCT00252174 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Psychotherapy is the first listed.
NCT00252174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00252174 about?
NCT00252174 is a clinical study titled "MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer". This is a pilot study intended to find out if 3,4-methylenedioxymethamphetamine (MDMA) is safe and can help people with advanced stage cancer and anxiety arising from the cancer diagnosis.
What is the current status of trial NCT00252174?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2007-02. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00252174?
The interventions under investigation include: Psychotherapy (BEHAVIORAL), Stage 1 Active Methylenedioxymethamphetamine (DRUG), Stage 1 Low dose Methylenedioxymethamphetamine (DRUG), Stage 2 Active Methylenedioxymethamphetamine (DRUG).
Who is sponsoring clinical trial NCT00252174?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00252174's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia